In-vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely popular treatments, which has assisted couples with infertility problems, single mothers and the LGBT community to procreate. The global IVF devices market would witness a substantial growth in future owing to rising incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures and increased occurrences of gamete donations. Furthermore, rising health awareness on fertility issues, availability of IVF treatments, increasing disposable income and favorable reimbursement policies would further augment the market growth. Recent innovations in IVF technology, such as Embryoscope and capsule IVF, are anticipated to augment the demand of IVF devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies and ethical considerations are likely to hinder the market growth. Increasing upsurge of fertility clinics and same sex marriages would offer lucrative growth opportunities in future. In addition, fertility tourism would provide ample growth opportunities especially in the developing economies. The global IVF devices and consumables market accounted for $1,252.8 million in 2014 and is forecast to garner $3,627.2 million by 2020, registering a promising CAGR of 19.2% during the forecast period.
The global IVF devices market comprises five key segments namely, IVF instruments, reagents and media, technology, end users and geography. The instruments market considered in this report include, sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF accessories and disposables, and others. In the instruments market, micromanipulator is the highest revenue-generating segment owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment would witness a significant growth due to its extensive use in healthy sperm selection and gender determination.
Based on reagents and media, the global IVF devices market is categorized into cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue-generating segment due to its extensive use in frozen IVF cycles. IVF devices and consumables market by techniques is categorized into fresh embryo transfer technique, frozen egg transfer technique and donor egg transfer technique. In the current market scenario, fresh embryo transfer technique is the highest revenue-generating segment and would continue to maintain this trend during the forecast period owing to the higher user preference for this technique.
The global IVF devices market by end-users is segmented into fertility clinics, hospitals, surgical centers and clinical research institutes. Fertility clinics is the highest revenue-generating segment in the IVF market due to easy accessibility of IVF treatment and services and high success rates. Furthermore, surgical centers is forecast to exhibit rapid growth due to the use of sophisticated IVF technologies.
The global IVF devices market has been analyzed on the basis of geographical regions, which include North America, Europe, Asia Pacific and LAMEA. Europe and North America are the dominant regions of this market, collectively accounting for about 79% of the total market share. This is mainly attributed to the widespread adoption of advanced technologies, healthcare awareness, favorable reimbursement policies and supportive legal frameworks. Nevertheless, Asia Pacific would emerge as the fastest growing region owing to low manufacturing costs of IVF devices and increasing popularity of medical tourism. Moreover, availability of skilled personnel and rising awareness would further augment the market growth in this region.
The competitive landscape of the IVF devices market indicates the presence of local as well as global IVF device manufacturers. Product launch has been the prime growth strategy adopted by the major market players to improve their market share. Some of the prominent product launches include micromanipulators systems, ovum aspiration pumps and IVF accessories. These technologies are used in both clinical and research fields. The key companies profiled in this report include, Vitrolife AB, EMD Serono, Inc., Irvine Scientific, Cooper Surgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology and OvaScience, Inc.
1.1 KEY MARKET BENEFITS
An in-depth analysis of the current research and clinical developments in the global IVF devices market has been provided with key factors to understand the market scenario.
The projections in the report are based on the analysis of the current market trends and future market potential in terms of value during the period of 2014‐2020.
An exhaustive analysis of the global IVF devices market by instruments helps in understanding the type of devices that are currently being used along with the variants that would gain prominence in future.
Competitive intelligence of leading manufacturers and distributors of IVF devices highlights the business practices followed by leading market players across various geographies.
SWOT analysis facilitates the study of the internal environment of prominent companies for strategy formulation.
A comprehensive analysis of the market has been conducted by closely monitoring key products of top contenders in the market.
1.2 KEY MARKET SEGMENTS
The global IVF devices market is segmented on the basis of instruments, reagents and media, techniques, end users and geography.
Global IVF Devices Market - By Instruments
Ovum aspiration pump
Sperm separation system
Accessories and disposables
Global IVF Devices Market - By Reagents and Media
Semen processing media
Ovum processing media
Embryo culture media
Global IVF Devices Market - By Technology
Fresh embryo transfer technique
Frozen embryo transfer technique
Donor egg IVF technique
Global IVF Devices Market - By End Users
Clinical research institutes
Global IVF Devices Market - By Geography
The IVF market analyzed in this report includes the various technologies of in-vitro fertilization along with the instruments, reagents and media used during the procedures. The market is segmented into instruments, reagents and media, technology and end users. This report excludes the in depth analysis of IVF in the service market and drugs market.
The scope of the market in the upcoming years is increase in technological advancement, high success rates, cost efficient treatments, and uncomplicated procedures that would save both the patients as well as the doctor’s time.
This market has growth opportunities in the geographic areas such as Asia pacific and RoW, where the rate of infertility is increasing and need for better IVF techniques that are cost efficient.
This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.
Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
The demands of diagnostic markets are increasing. Where conventional diagnostic tools were focused on producing accurate and consistent results, todayâ€™s market demand extend to early diagnosis with accurate and consistent results. There are significant challenges in presenting accurate results in the early stage of diseases, especially in case of cancer.
A hernia is a type of disease in which the inner layers of abdominal muscle become weakened and the lining of the abdomen then bulges out into a small sac. Hernias can occur in several places, such as the navel (umbilical hernia), groin (inguinal hernia), and at the incision site of surgery (post-surgery hernia). Hernia can be treated in two ways, i.e. watchful waiting and surgical procedures.
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020. The global companion diagnostic market is segmented based on indication, technology and geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the fastest growing region. The key drivers for this market are the increase in the discovery of biomarkers and co-development of drug and corresponding diagnostic. However, cost associated with developing drugs could impede the growth of this market.
Temperature management is a treatment carried out to maintain specific body temperature of a patient for specific duration. It improves health conditions and reduces risks of tissue injuries occurring due to lack of blood flow. The prevention of brain injuries and improvement in brain function following a cardiac arrest is possible using temperature management techniques. It also prevents secondary neurological injuries after central nervous systems trauma in animals.
Next generation sequencers are used in sequencing technologies which can process millions of reactions in a massive parallel fashion, unlike older methods which were limited to a single or few DNA strands. This technology allows the rapid sequencing of millions of base pairs of DNA spanning entire genomes.
The focus on enhanced safety and quality of healthcare products, hygiene & safety of working personnel, along with environmental concerns propels the usage of cleanrooms in the healthcare industry. The framing of favorable regulations about the use of cleanroom technology in the healthcare industry is a factor that boosts the market growth. Moreover, emergence of biologics are expected to spur the demand for cleanrooms across healthcare industry verticals.